Eomesodermin driven IL-10 production in effector CD8(+) T cells promotes a memory phenotype.

類似資料

• Eomesodermin increases survival and IL-2 responsiveness of tumor-specific CD8(+) T cells in an adoptive transfer model of cancer immunotherapy
  著者:: Furusawa, Aki, 等
  出版事項: (2018)
• Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response
  著者:: Reiser, John, 等
  出版事項: (2016)
• Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response
  著者:: John Reiser, 等
  出版事項: (2016-01-01)
• Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
  著者:: Song, Chang, 等
  出版事項: (2014)
• The Transcription Factor Eomesodermin Enables CD8(+) T Cells to Compete for the Memory Cell Niche
  著者:: Banerjee, Arnob, 等
  出版事項: (2010)